合并下肢深静脉血栓对症状性和偶然性肺栓塞结局的影响:一项单中心前瞻性队列研究
该单中心前瞻性队列研究纳入2013年3月1日至2021年6月30日确认的急性症状性或偶然性肺栓塞(PE)且接受超声检查的连续患者1907例,按有无下肢深静脉血栓(DVT)分组。合并下肢DVT组920例,无DVT组987例。无合并DVT组全因死亡率显著高于合并DVT组(42.4/100人年 vs 29.6/100人年,P < .001),静脉血栓栓塞复发和出血无差异。按癌症状态分层后,死亡率差异仅见于非癌症患者(15.2/100人年 vs 12.1/100人年,P = .046)。
要点
- 无合并下肢DVT的PE患者全因死亡率显著高于合并DVT者(42.4/100人年 vs 29.6/100人年,P < .001)。
- 按癌症状态分层后,死亡率差异仅见于非癌症患者(15.2/100人年 vs 12.1/100人年,P = .046)。
- 合并与不合并下肢DVT的PE患者静脉血栓栓塞复发和出血结局无差异。
核心结论
- 在急性PE患者中,无合并下肢DVT与显著更高的死亡率相关。
- 死亡率差异仅见于非癌症患者。
- 未观察到静脉血栓栓塞复发或出血的差异。
研究设计与样本
- 单中心前瞻性队列研究,连续纳入2013年3月1日至2021年6月30日确认的急性症状性或偶然性PE且接受超声检查的患者。
- 共1907例患者,按有无下肢DVT分为合并DVT组(n=920)和无DVT组(n=987)。
- 前瞻性随访静脉血栓栓塞复发、出血和全因死亡率。
主要发现
- 合并下肢DVT组患者年龄更大、体重更重,创伤、制动、易栓症和静脉血栓栓塞史频率显著更高。
- 无下肢DVT组活动性癌症、转移性疾病和活动性全身治疗使用率更高。
- 全因死亡率(每100人年)无合并DVT组显著高于合并DVT组(42.4/100人年 vs 29.6/100人年,P < .001)。
- 按癌症状态分层后,非癌症患者中无合并DVT组死亡率仍显著高于合并DVT组(15.2/100人年 vs 12.1/100人年,P = .046)。
- 静脉血栓栓塞复发和出血结局无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognostic implications of co-incident DVT at the time of PE diagnosis remains unclear. OBJECTIVES: Study aims were to assess the impact of co-incident lower extremity (LE) deep vein thrombosis (DVT) on clinical outcomes of pulmonary embolism (PE) including venous thromboembolism (VTE) recurrence and mortality. METHODS: Consecutive patients with confirmed acute symptomatic or incidental PE (March 1, 2013 to June 30, 2021) who underwent ultrasound imaging were divided into two groups depending on the presence or absence of LE DVT. Patients were followed prospectively for VTE recurrence, bleeding, and all-cause mortality. RESULTS: Over the study period, 1907 patients with PE were stratified into groups based on the presence (n = 920) or absence (n = 987) of LE DVT. Patients with co-incident LE DVT were older, heavier, and had a significantly greater frequency of trauma, confinement, thrombophilia, and VTE. Those without LE DVT had a higher prevalence of active cancer, metastatic disease, and active systemic therapy use. All-cause mortality rates (per 100 person-years) were significantly higher for patients without vs with co-incident LE DVT (42.4/100 person-years vs 29.6/100 person- years; P < .001) with no differences in VTE recurrence or bleeding outcomes. After stratification by cancer status, mortality in those without vs. with co-incident DVT only remained significant among noncancer patients (15.2/100 person-years vs 12.1/100 person-years, P = .046). CONCLUSIONS: Among patients with acute PE, the absence of co-incident lower extremity DVT is associated with significantly higher mortality rates. Mortality rate differences were only observed for those without cancer. No differences in VTE recurrence or bleeding were observed.
引用
- Callori S, Wysokinsk W, Vlazny D, et al. Impact of coincident lower extremity deep vein thrombosis on symptomatic and incidental pulmonary embolism outcomes. A single-center prospective cohort study. J Thromb Haemost. 2024. PMID: 39746398. doi:10.1016/j.jtha.2024.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。